Shelf life (days): 1460.0
Formulation: A crystalline solid
Formal Name: N-(2-chloro-5-pyrimidinyl)-3,4-difluoro-benzamide
Purity: ≥98%
Formula Markup: C11H6ClF2N3O
Formula Weight: 269.6
CAS Number: 582323-16-8
Notes: ICA 069673 is a heteromeric Kv7 channel activator.{39323,39324} It is selective for Kv7.2/7.3 over Kv7.3/7.5 (EC50s = 0.69 and 14.3 μM, respectively) and also activates Kv7.4, Kv7.5, and heteromeric Kv7.4/7.5 channels in a dose-dependent manner.{39324} ICA 069673 has no activity against hERG, Nav1.5, and Kv7.1 cardiac ion channels (IC50s = >30 μM).{39323} Oral administration of ICA 069673 increases latency to first tonic-clonic seizure in the rat maximal electroshock and pentylentetrazol-induced seizure models (ED50s = 1.5 and <1 mg/kg, respectively).{39323} Formulations containing ICA 069673 are under clinical investigation for the treatment of epilepsy.
English
Deutsch
